Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Herrlinger

Showing results (11-20 of 243) with videos related to

Pageof 25
Sort By:
Journal of Neurology|May 17, 2005
Relapse of primary CNS lymphoma after more than 10 years in complete remissionUlrich Herrlinger, Holger Hebart, Lothar Kanz, et al.
Seminars in Oncology|August 8, 2009
Should intra-cerebrospinal fluid prophylaxis be part of initial therapy for patients with non-Hodgkin lymphoma: what we know, and how we can find out moreUlrich Herrlinger, Michael Glantz, Uwe Schlegel, et al.
Journal of Neuro-Oncology|July 20, 2019
Longitudinal, leakage corrected and uncorrected rCBV during the first-line treatment of glioblastoma: a prospective studyEike Steidl, Mathias Müller, Andreas Müller, et al.
European Radiology|August 28, 2003
Recurrent delayed brain hemorrhage over years after irradiation and chemotherapy for astrocytomaAndreas Hillemanns, Rolf-Dieter Kortmann, Ulrich Herrlinger, et al.
Journal of Neuro-Oncology|March 16, 2004
MIP-1alpha antagonizes the effect of a GM-CSF-enhanced subcutaneous vaccine in a mouse glioma modelUlrich Herrlinger, Steffen Aulwurm, Herwig Strik, et al.
Cancers|May 14, 2022
Impact of Levetiracetam Treatment on 5-Aminolevulinic Acid Fluorescence Expression in IDH1 Wild-Type GlioblastomaJohannes Wach, Ági Güresir, Motaz Hamed, et al.
Journal of Neuro-Oncology|March 1, 2005
UKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastomaUlrich Herrlinger, Johannes Rieger, Joachim P Steinbach, et al.
Biochemical and Biophysical Research Communications|January 27, 2005
Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomasMartin Uhl, Markus Weiler, Wolfgang Wick, et al.
American Journal of Medical Genetics. Part A|July 11, 2019
PDGRFB mutation-associated myofibromatosis: Response to targeted therapy with imatinibJohannes M Weller, Vera C Keil, Gerrit H Gielen, et al.
Radiation Oncology (London, England)|August 13, 2011
Successful radiopeptide targeting of metastatic anaplastic meningioma: case reportAmir Sabet, Hojjat Ahmadzadehfar, Ulrich Herrlinger, et al.
Pageof 25

Showing results (11-20 of 243) with videos related to

Sort By:
Pageof 25
Journal of Neurology|May 17, 2005
Relapse of primary CNS lymphoma after more than 10 years in complete remissionUlrich Herrlinger, Holger Hebart, Lothar Kanz, et al.
Seminars in Oncology|August 8, 2009
Should intra-cerebrospinal fluid prophylaxis be part of initial therapy for patients with non-Hodgkin lymphoma: what we know, and how we can find out moreUlrich Herrlinger, Michael Glantz, Uwe Schlegel, et al.
Journal of Neuro-Oncology|July 20, 2019
Longitudinal, leakage corrected and uncorrected rCBV during the first-line treatment of glioblastoma: a prospective studyEike Steidl, Mathias Müller, Andreas Müller, et al.
European Radiology|August 28, 2003
Recurrent delayed brain hemorrhage over years after irradiation and chemotherapy for astrocytomaAndreas Hillemanns, Rolf-Dieter Kortmann, Ulrich Herrlinger, et al.
Journal of Neuro-Oncology|March 16, 2004
MIP-1alpha antagonizes the effect of a GM-CSF-enhanced subcutaneous vaccine in a mouse glioma modelUlrich Herrlinger, Steffen Aulwurm, Herwig Strik, et al.
Cancers|May 14, 2022
Impact of Levetiracetam Treatment on 5-Aminolevulinic Acid Fluorescence Expression in IDH1 Wild-Type GlioblastomaJohannes Wach, Ági Güresir, Motaz Hamed, et al.
Journal of Neuro-Oncology|March 1, 2005
UKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastomaUlrich Herrlinger, Johannes Rieger, Joachim P Steinbach, et al.
Biochemical and Biophysical Research Communications|January 27, 2005
Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomasMartin Uhl, Markus Weiler, Wolfgang Wick, et al.
American Journal of Medical Genetics. Part A|July 11, 2019
PDGRFB mutation-associated myofibromatosis: Response to targeted therapy with imatinibJohannes M Weller, Vera C Keil, Gerrit H Gielen, et al.
Radiation Oncology (London, England)|August 13, 2011
Successful radiopeptide targeting of metastatic anaplastic meningioma: case reportAmir Sabet, Hojjat Ahmadzadehfar, Ulrich Herrlinger, et al.
Pageof 25